Long Island Jewish Valley Stream Hospital 1st in the Nation to Receive 5 Orthopedic Specialty Certifications

Long Island Jewish Valley Stream Hospital (LIJVS) has become the first hospital in the country to receive all five orthopedic specialty certifications available from the Joint Commission.

Long Island Jewish Valley Stream Hospital is now certified in: advanced spine surgery, advanced total hip and knee replacement, total shoulder replacement, total ankle replacement and hip fracture care surgeries.

The Joint Commission is an independent regulatory organization that sets standards for healthcare programs in the United States through core and advanced disease specific certifications. These certifications are benchmarks for excellence in patient care and surgical outcomes. LIJVS becoming the first hospital in the country to receive all five Joint Commission certifications is a result of the orthopedic program’s quality and growth which led to the orthopedic unit being named the Orthopedic Hospital at Long Island Jewish Valley Stream.

“At Long Island Jewish Valley Stream, our goal has always been to give great care to our patients” said James Germano, MD, chair, orthopedics, Long Island Jewish Valley Stream Hospital. “Certifications like these are really to show the community how hard we work and how committed we are to achieving the best in comprehensive orthopedic care.”

The quality measures analyzed by the Joint Commission include areas of safety, patient optimization, process efficiency and the return of independence and restoration of quality of life for patients. The certification process requires the hospital to submit its orthopedic program design for all surgeons and specialties as well as nursing standards and rehabilitation protocols. The Joint Commission reviewers also make a lengthy onsite visit to review program standards and processes and observe surgeries and care delivery. The onsite visit includes interaction with surgeons, nurses, physical therapists and patients to help reviewers assess the program in person.

“It has been incredibly meaningful for me to receive feedback from the various Joint Commission reviewers who surveyed our program,” said Jason Tan, RN executive director, Long Island Jewish Valley Stream. “Every single reviewer consistently said that they could feel the commitment, dedication and love our team members have for our patients and for this mission. We are very proud to be the first hospital in the country to receive all five Joint Commission certifications for our orthopedic program at Long Island Jewish Valley Stream.”

For more information about the Orthopedic Hospital at Long Island Jewish Valley Stream call:516-321-7591

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version